Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Elizabeth Orr

Washington, DC
Elizabeth Orr focuses on legal affairs affecting the medical device industry. Before joining Informa in September 2015, she spent three years spent reporting on all things device-related at FDANews. She remains fascinated by the ever-changing master class on technology, government regulations, advances in health care and more that is covering the device industry. Elizabeth’s past employers include DecisionHealth (formerly UCG); the Society of Interventional Radiology; and the Washington Examiner.  A graduate of the College of Journalism at the University of Maryland College Park, she lives in Arlington, Va., with her husband and children.
Set Alert for Articles By Elizabeth Orr

Latest From Elizabeth Orr

Abiomed Settles Kickback Allegation Tied To Pricey Meals

Heart-pump manufacturer Abiomed has agreed to pay $3.1m to resolve allegations the company violated the US False Claims Act by spending lavishly on physicians.

Legal Issues Commercial

FDA Works To Connect Cardiac Device Registries

US FDA is working with manufacturers, researchers and other stakeholders to assemble a comprehensive network of registries of cardiac device data. But cardiologists and device firms say the project faces multiple challenges.

Regulation Research & Development

Medtronic Announces End To Shareholder Infuse Case

A long-running shareholder case against Medtronic has come to an end after the US Supreme Court refused to hear the plaintiff's appeal.

Commercial Legal Issues

Class-Action Securities Suits On The Rise Against Life-Science Firms, Especially Smaller Ones

A recent report from law firm Dechert LLP shows that the number of class-action cases brought against life-sciences companies has spiked in recent years, up from 27 in 2012 to 88 in 2017. The trend is most pronounced against smaller-cap companies, an attorney behind the report explains.

Legal Issues Compliance

Contact-Lens Prescription Process Debated At US Trade Commission

The US Federal Trade Commission hosted a sometimes-contentious discussion on proposed changes to its Contact Lens Rule on March 8. One issue up for debate was which methods are appropriate when a contact-lens seller needs to confirm a prescription with a patient's eye doctor.

Policy Distribution

Device Week, March 9, 2018 – US Policy Updates: CMS, FTC, FDA, Supreme Court

On this week's podcast, we discuss US medtech policy developments from the Centers for Medicare and Medicaid Services, the Federal Trade Commission, FDA and the Supreme Court.

Policy Regulation
See All